Bio-Rad Laboratories: Top 25 Undervalued S&P 500 Composite Index Stocks (BIO)
Bio-Rad Laboratories is now ranked among the top 25 undervalued stocks included in the S&P 500 Composite Index. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).
Stocks in this market cap category are held primarily for capital appreciation and/or dividends. Inclusion in a major index means a company ranks among the largest in their market. This also implies stability by-way of institutional support for the stock by index funds.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| AAL-Q | American Airlines Group | 15.57 | 24.67 | 9.1 (58.43) | 22,990,189 | 10,224.9 | 0 | 5.7 |
| AAP-N | Advance Auto Parts | 63.58 | 142.03 | 78.45 (123.39) | 3,413,486 | 3,785.8 | 9.4 | 9.4 |
| HBI-N | Hanesbrands | 4.62 | 7.75 | 3.13 (67.78) | 7,342,345 | 1,619 | 9.7 | 0 |
| VTRS-Q | Viatris | 9.38 | 13.71 | 4.33 (46.16) | 8,951,788 | 11,308.5 | 5.1 | 6 |
| IP-N | International Paper | 31.68 | 56.16 | 24.48 (77.29) | 3,538,496 | 11,192.5 | 5.8 | 7 |
| FIS-N | Fidelity National Info | 54.66 | 117.81 | 63.15 (115.53) | 4,944,499 | 32,413.4 | 3.6 | 0 |
| OGN-N | Organon | 19.83 | 32.15 | 12.32 (62.11) | 2,235,791 | 5,079.9 | 5.7 | 6.8 |
| MMM-N | 3M | 99.9 | 177.2 | 77.3 (77.38) | 4,179,211 | 55,264.699 | 6 | 10.3 |
| ARE-N | Alexandria Real Estate | 120.59 | 168.71 | 48.12 (39.9) | 937,806 | 20,594.801 | 4 | 26.3 |
| LNC-N | Lincoln National | 23.1 | 43.74 | 20.64 (89.36) | 2,958,836 | 3,938.2 | 7.8 | 0 |
| MRNA-Q | Moderna | 123.26 | 228.87 | 105.61 (85.68) | 3,153,285 | 49,920.301 | 0 | 10.5 |
| SWK-N | Stanley Black & Decker | 84.6 | 123.42 | 38.82 (45.89) | 1,584,213 | 12,654 | 3.8 | 0 |
| NWL-Q | Newell Brands | 8.48 | 13.8 | 5.32 (62.79) | 9,042,509 | 3,509.9 | 9 | 0 |
| T-N | AT&T | 15.95 | 22.93 | 6.98 (43.79) | 45,177,747 | 119,210.297 | 7 | 0 |
| DD-N | DuPont de Nemours | 69.67 | 133.35 | 63.68 (91.4) | 3,717,644 | 32,062.1 | 2 | 32 |
| NCLH-N | Norwegian Cruise Line | 17.17 | 26.21 | 9.04 (52.67) | 12,913,637 | 7,257 | 0 | 0 |
| CTLT-N | Catalent | 38.81 | 66.51 | 27.7 (71.39) | 4,904,912 | 7,144.6 | 0 | 17 |
| CCL-N | Carnival | 13.09 | 19.23 | 6.14 (46.91) | 33,158,606 | 16,493.4 | 0 | 0 |
| INCY-Q | Incyte | 61.04 | 87.33 | 26.29 (43.08) | 1,665,439 | 13,770 | 0 | 42.1 |
| CPB-N | Campbell Soup | 46.05 | 63.55 | 17.5 (38) | 3,327,965 | 13,861 | 3.2 | 17.6 |
| LUMN-N | Lumen Technologies | 1.8 | 5.18 | 3.38 (187.93) | 21,935,508 | 1,768.1 | 27.8 | 0 |
| BIO-N | Bio-Rad Laboratories | 361.03 | 529.05 | 168.02 (46.54) | 244,226 | 10,739.6 | 0 | 0 |
| IFF-N | Intl Flavors & Fragrances | 78.24 | 117.4 | 39.16 (50.05) | 1,986,926 | 19,951.199 | 4.1 | 0 |
| VNO-N | Vornado Realty | 15.43 | 27.79 | 12.36 (80.08) | 3,482,789 | 2,960.7 | 12.7 | 0 |
| UAA-N | Under Armour | 7.43 | 12.06 | 4.63 (62.33) | 7,560,726 | 3,429 | 0 | 8.8 |
More about Bio-Rad Laboratories
All data provided as-at market close June 08, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Bio-Rad Laboratories Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials. Bio-Rad Laboratories is listed under BIO on the New York Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
